Ascendant Diagnostics is a Biotechnology Company Focused on New Approaches to the Diagnosis of Serious Diseases and Conditions
Ascendant Diagnostics is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.
New Screening Test Encourages Wider Participation
Ascendant Diagnostic’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer. We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods.